Cue Biopharma, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Cue Biopharma, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Cantor Global Healthcare Conference 2025

Sep 5, 2025

Transcript

Q2 2025

Aug 12, 2025

Quarterly report10-Q

Earnings release8-K

Q1 2025

May 12, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 31, 2025

Earnings release8-K

Annual report10-K

Q3 2024

Nov 14, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 19, 2024

Earnings release8-K

Q1 2024

May 9, 2024

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Apr 8, 2024

Slides

2023

Q4 2023

Apr 8, 2024

Earnings release8-K

Annual report10-K

Investor Presentation

Nov 22, 2023

Slides

Q3 2023

Nov 9, 2023

Earnings release8-K

Q2 2023

Aug 9, 2023

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Aug 9, 2023

Slides

Investor Update

Jun 14, 2023

Press release

Q1 2023

May 9, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 21, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 14, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 23, 2022

Earnings release8-K

Study Update

Jan 26, 2022

Slides

Press release

2021

Q4 2021

Mar 16, 2022

Annual report10-K

Q2 2021

Aug 17, 2021

Earnings release8-K

2020

Q4 2020

Mar 9, 2021

Annual report10-K

2019

Q4 2019

Mar 12, 2020

Annual report10-K

2018

Q4 2018

Mar 14, 2019

Annual report10-K

2017

Q4 2017

Mar 29, 2018

Annual report10-K